Human parvovirus B19 infection within a family and risk for pregnant women

Epidemiology and Infection

Volumn 117, Issue 2, 1996, Pages 401-403

  Azzi, A ^a   Trotta, M ^b   Zakrzewska, K ^a   Balzer, E ^b   Rogasi, P G ^b   Carocci, A ^b   Leoncini, F ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY;

ARTICLE; CLINICAL ARTICLE; ERYTHEMA INFECTIOSUM; FEMALE; HOUSEHOLD; HUMAN; IMMUNOFLUORESCENCE TEST; MALE; NEWBORN; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATION; RISK;

EID: 0029859735     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/s095026880000159x     Document Type: Article

References (15)

1. Cohen BJ, Buckley MM. The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol 1988; 25: 151-3.
2. Anderson LJ. Role of parvovirus B19 in human disease. Pediatr Infect Dis J 1987; 6: 711-8.
3. Anderson MJ, Higgins PG, Davis LR, et al. Experimental parvovirus infection in humans. J Infect Dis 1985; 152: 257-65.
4. Bartolomei Corsi O, Azzi A, Morflni M, Fanci R, Rossi Ferrini P. Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates. J Med Virol 1988; 25: 165-70.
5. Anand A, Gray ES, Brown T, Clewley JP, Cohen BJ. Human parvovirus infection in pregnancy and hydrops fetalis. N Engl J Med 1987; 316: 183-6.
6. Anderson LJ, Gillespie SM, Torok TJ, Hurwitz ES, Tsou CJ, Gary GW. Risk of B19 infection following exposures to human parvovirus. Behring Inst Mitt 1990; 85: 60-3.
7. Bell LM, Naides SJ, Stoffman P, Hodinka RL, Plotkin SA. Human parvovirus infection among hospital staff members after contact with infected patients. N Engl J Med 1989; 321: 485-91.
8. Public Health Laboratory Service Working Party on Fifth Disease. Prospective study of human parvovirus (B19) infection in pregnancy. BMJ 1990; 300: 1166-70.
9. Schwarz TF, Nerlich A, Roggendorf M. Parvovirus B19 infection in pregnancy. Berhing Inst Mitt 1990; 85: 69-73.
10. Brown KE, Spencer WG, Antunez de Mayolo J, et al. Congenital anaemia after transplacental B19 parvovirus infection. Lancet 1994; 343: 895-6.
11. Pattison JR. Human parvovirus B19. BMJ 1994; 308: 149-50.
12. Zakrzewska K, Azzi A, Patou G, Morfini M, Rafanelli D, Pattison JR. Human parvovirus B19 in clotting factor concentrates; B19 DNA detection by the nested polymerase chain reaction. Br J Haematol 1992; 81: 407-12.
13. Azzi A, Macchia PA, Favre C, Nardi M, Zakrzewska K, Bartolomei-Corsi O. Aplastic crisis caused by B19 virus in a child during induction therapy Tor acute lymphoblastic leukemia. Haematologica 1989; 74: 191-4.
14. Kurtzman GJ, Ozawa K, Cohen B, Hanson G, Oseas R, Young NS. Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med 1987; 317: 287-94.
15. Koch WC, Adler SP, Karger J. Intrauterine parvovirus B19 infection may cause an asymptomatic or recurrent postnatal infection. Pediatr J Infect Dis 1993; 12: 747-50.